Strong CAGR to Propel in the Albumin Market and Beyond upto $9.93 Billion by 2029

Global Albumin Market

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Albumin Market Growth Evolved From 2024 To 2025, And What’s Ahead?

The size of the albumin market has seen significant growth in the past few years. It is expected to rise from $6.57 billion in 2024 to $7.16 billion in 2025, showcasing a compound annual growth rate (CAGR) of 9.0%. The growth during the historic period has been propelled by improvements in biotechnology, surging demand for therapies derived from plasma, broadening utilization in pharmaceuticals, the high occurrence of liver diseases, approvals from regulatory bodies for products based on albumin, and the increasing globalization of healthcare that leads to enhanced market access.

The market size of albumin is predicted to witness significant expansion in the upcoming years, growing to be worth$9.93 billion in 2029″ with an average annual growth rate (CAGR) of 8.5%. This anticipated expansion for the forecast period can be accredited to an escalating occurrence of liver conditions, widened use in regenerative medicine, an increasing elderly population, modernizing diagnostic methods, a shift in the healthcare structure towards outpatient services, and an enhanced understanding of the need for maintaining suitable protein levels. Essential trends for the forecast period comprise of the expanding use of therapeutic applications, growing adoption in drug delivery systems, increased demand in cell culture media, advancements in personalized medicine, progression in recombinant technology, elevated consciousness about hypoalbuminemia therapy, and significant funding in research and development for the introduction of innovative albumin-based commodities.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16333&type=smp

Which Primay Drivers Are Accelerating Growth in the Albumin Market?

Due to the escalating number of diabetes cases, it is anticipated that the albumin market will expand significantly. Diabetes is a metabolic disorder defined by consistently elevated blood sugar levels. Malnutrition, insufficient physical exercise, hormonal imbalances, and obesity contribute to the increasing prevalence of diabetes. Albumin, a notable biomarker in the monitoring of diabetes, plays a key role in directing insulin treatment, supervising blood sugar control, aiding in diagnosis, and foreseeing complications like diabetic ketoacidosis (DKA). Proper management of diabetes relies heavily on maintaining normal albumin levels. As an example, the National Library of Medicine, a government library in the USA, reported in January 2022 that the global diabetes prevalence for 2021 was around 10.5%, impacting roughly 536.6 million people aged 20-79. Predictions for 2045 suggest this number will reach 12.2%, affecting about 783.2 million individuals. Hence, the surge in diabetes cases is set to fuel the future growth of the albumin market.

Which Primary Segments of the Albumin Market Are Driving Growth and Industry Transformations?

The albuminmarket covered in this report is segmented –

1) By Type: Human Serum Albumin; Bovine Serum Albumin; Recombinant Albumin

2) By Application: Therapeutics; Drug Formulation And Vaccines; Component Of Media; Other Applications

3) By Sales Channel: Business-To-Consumer (B2C); Business-To-Business (B2B)

4) By End-User: Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Research Institutes

Subsegments:

1) By Human Serum Albumin: Plasma-Derived Human Serum Albumin; Recombinant Human Serum Albumin; Human Serum Albumin For Therapeutic Use (In Liver Disease, Burns); Human Serum Albumin For Drug Delivery And Research Applications

2) By Bovine Serum Albumin: Bovine Serum Albumin For Laboratory Use (In Cell Culture); Bovine Serum Albumin For Diagnostic Kits; Bovine Serum Albumin As A Stabilizer In Vaccines And Biopharmaceuticals

3) By Recombinant Albumin: Recombinant Human Albumin For Therapeutic Applications; Recombinant Albumin For Biopharmaceutical Formulation; Recombinant Albumin For Cosmetic And Personal Care Applications; Recombinant Albumin For Research And Diagnostic Applications

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=16333&type=smp

Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Albumin Market?# Market?

North America was the largest region in the albumin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the albumin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Technological Trends Are Reshaping the Albumin Industry Dynamics?

Leading firms in the albumin market are pioneering new products like animal- and human-origin-free recombinant albumin, providing customers with improved features. This kind of albumin is produced through a non-mammalian expression system like yeast, and does not include any elements from animals or humans. For example, in March 2023, Albumedix, a UK-based producer of recombinant human albumin (rHA), partnered with Heartseed Inc., a clinical-stage biotech company from Japan, to introduce Recombin, a crucial excipient for the manufacture of Heartseed’s experimental cell therapy, HS-001, as it begins its first human clinical trial. This partnership represents a major breakthrough in the progression of HS-001, and is set to drastically change the way various diseases are treated. The incorporation of recombination in the production process guarantees superior performance and durability of the cell therapy, further strengthening its potential for therapeutic triumph.

View the full report here:

https://www.thebusinessresearchcompany.com/report/albumin-global-market-report

What Parameters Are Used to Define the Albumin Market?

Albumin is a type of protein found in blood plasma, serum, muscle, the whites of eggs, milk, and other animal substances, as well as in many plant tissues and fluids. It is a simple, heat-coagulable, and water-soluble protein that plays a crucial role in maintaining fluid balance and transporting hormones, vitamins, and enzymes throughout the body.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16333

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model